Global Kidney Disease Drugs Sales Market Report 2024

Report ID: 884164 | Published Date: Oct 2024 | No. of Page: 149 | Base Year: 2023 | Rating: 4.6 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Kidney Disease Drugs Market Overview
    1.1 Kidney Disease Drugs Product Scope
    1.2 Kidney Disease Drugs Segment by Type
        1.2.1 Global Kidney Disease Drugs Sales by Type (2016 & 2021 & 2027)
        1.2.2 Tablets
        1.2.3 Capsule
        1.2.4 Other
    1.3 Kidney Disease Drugs Segment by Application
        1.3.1 Global Kidney Disease Drugs Sales Comparison by Application (2016 & 2021 & 2027)
        1.3.2 Chronic Glomerulonephritis
        1.3.3 Nephrotic Syndrome
        1.3.4 Chronic Renal Failure
        1.3.5 Kidney Stones
        1.3.6 Renal Cyst (polycystic Kidney)
        1.3.7 Diabetic Nephropathy
        1.3.8 Hypertensive Nephropathy
        1.3.9 Purpura Nephritis
        1.3.10 Lupus Nephritis
        1.3.11 Pediatric Kidney Disease
    1.4 Kidney Disease Drugs Market Estimates and Forecasts (2016-2027)
        1.4.1 Global Kidney Disease Drugs Market Size in Value Growth Rate (2016-2027)
        1.4.2 Global Kidney Disease Drugs Market Size in Volume Growth Rate (2016-2027)
        1.4.3 Global Kidney Disease Drugs Price Trends (2016-2027)

2 Kidney Disease Drugs Estimates and Forecasts by Region
    2.1 Global Kidney Disease Drugs Market Size by Region: 2016 VS 2021 VS 2027
    2.2 Global Kidney Disease Drugs Retrospective Market Scenario by Region (2016-2021)
        2.2.1 Global Kidney Disease Drugs Sales Market Share by Region (2016-2021)
        2.2.2 Global Kidney Disease Drugs Revenue Market Share by Region (2016-2021)
    2.3 Global Kidney Disease Drugs Market Estimates and Forecasts by Region (2022-2027)
        2.3.1 Global Kidney Disease Drugs Sales Estimates and Forecasts by Region (2022-2027)
        2.3.2 Global Kidney Disease Drugs Revenue Forecast by Region (2022-2027)
    2.4 Geographic Market Analysis: Market Facts & Figures
        2.4.1 North America Kidney Disease Drugs Estimates and Projections (2016-2027)
        2.4.2 Europe Kidney Disease Drugs Estimates and Projections (2016-2027)
        2.4.3 China Kidney Disease Drugs Estimates and Projections (2016-2027)
        2.4.4 Japan Kidney Disease Drugs Estimates and Projections (2016-2027)
        2.4.5 Southeast Asia Kidney Disease Drugs Estimates and Projections (2016-2027)
        2.4.6 India Kidney Disease Drugs Estimates and Projections (2016-2027)
3 Global Kidney Disease Drugs Competition Landscape by Players
    3.1 Global Top Kidney Disease Drugs Players by Sales (2016-2021)
    3.2 Global Top Kidney Disease Drugs Players by Revenue (2016-2021)
    3.3 Global Kidney Disease Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Kidney Disease Drugs as of 2020)
    3.4 Global Kidney Disease Drugs Average Price by Company (2016-2021)
    3.5 Manufacturers Kidney Disease Drugs Manufacturing Sites, Area Served, Product Type
    3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Kidney Disease Drugs Market Size by Type
    4.1 Global Kidney Disease Drugs Historic Market Review by Type (2016-2021)
        4.1.1 Global Kidney Disease Drugs Sales Market Share by Type (2016-2021)
        4.1.2 Global Kidney Disease Drugs Revenue Market Share by Type (2016-2021)
        4.1.3 Global Kidney Disease Drugs Price by Type (2016-2021)
    4.2 Global Kidney Disease Drugs Market Estimates and Forecasts by Type (2022-2027)
        4.2.1 Global Kidney Disease Drugs Sales Forecast by Type (2022-2027)
        4.2.2 Global Kidney Disease Drugs Revenue Forecast by Type (2022-2027)
        4.2.3 Global Kidney Disease Drugs Price Forecast by Type (2022-2027)
5 Global Kidney Disease Drugs Market Size by Application
    5.1 Global Kidney Disease Drugs Historic Market Review by Application (2016-2021)
        5.1.1 Global Kidney Disease Drugs Sales Market Share by Application (2016-2021)
        5.1.2 Global Kidney Disease Drugs Revenue Market Share by Application (2016-2021)
        5.1.3 Global Kidney Disease Drugs Price by Application (2016-2021)
    5.2 Global Kidney Disease Drugs Market Estimates and Forecasts by Application (2022-2027)
        5.2.1 Global Kidney Disease Drugs Sales Forecast by Application (2022-2027)
        5.2.2 Global Kidney Disease Drugs Revenue Forecast by Application (2022-2027)
        5.2.3 Global Kidney Disease Drugs Price Forecast by Application (2022-2027)

6 North America Kidney Disease Drugs Market Facts & Figures
    6.1 North America Kidney Disease Drugs Sales by Company
        6.1.1 North America Kidney Disease Drugs Sales by Company (2016-2021)
        6.1.2 North America Kidney Disease Drugs Revenue by Company (2016-2021)
    6.2 North America Kidney Disease Drugs Sales Breakdown by Type
        6.2.1 North America Kidney Disease Drugs Sales Breakdown by Type (2016-2021)
        6.2.2 North America Kidney Disease Drugs Sales Breakdown by Type (2022-2027)
    6.3 North America Kidney Disease Drugs Sales Breakdown by Application
        6.3.1 North America Kidney Disease Drugs Sales Breakdown by Application (2016-2021)
        6.3.2 North America Kidney Disease Drugs Sales Breakdown by Application (2022-2027)

7 Europe Kidney Disease Drugs Market Facts & Figures
    7.1 Europe Kidney Disease Drugs Sales by Company
        7.1.1 Europe Kidney Disease Drugs Sales by Company (2016-2021)
        7.1.2 Europe Kidney Disease Drugs Revenue by Company (2016-2021)
    7.2 Europe Kidney Disease Drugs Sales Breakdown by Type
        7.2.1 Europe Kidney Disease Drugs Sales Breakdown by Type (2016-2021)
        7.2.2 Europe Kidney Disease Drugs Sales Breakdown by Type (2022-2027)
    7.3 Europe Kidney Disease Drugs Sales Breakdown by Application
        7.3.1 Europe 149 Sales Breakdown by Application (2016-2021)
        7.3.2 Europe 149 Sales Breakdown by Application (2022-2027)

8 China Kidney Disease Drugs Market Facts & Figures
    8.1 China Kidney Disease Drugs Sales by Company
        8.1.1 China Kidney Disease Drugs Sales by Company (2016-2021)
        8.1.2 China Kidney Disease Drugs Revenue by Company (2016-2021)
    8.2 China Kidney Disease Drugs Sales Breakdown by Type
        8.2.1 China Kidney Disease Drugs Sales Breakdown by Type (2016-2021)
        8.2.2 China Kidney Disease Drugs Sales Breakdown by Type (2022-2027)
    8.3 China Kidney Disease Drugs Sales Breakdown by Application
        8.3.1 China 314 Sales Breakdown by Application (2016-2021)
        8.3.2 China 314 Sales Breakdown by Application (2022-2027)

9 Japan Kidney Disease Drugs Market Facts & Figures
    9.1 Japan Kidney Disease Drugs Sales by Company
        9.1.1 Japan Kidney Disease Drugs Sales by Company (2016-2021)
        9.1.2 Japan Kidney Disease Drugs Revenue by Company (2016-2021)
    9.2 Japan Kidney Disease Drugs Sales Breakdown by Type
        9.2.1 Japan Kidney Disease Drugs Sales Breakdown by Type (2016-2021)
        9.2.2 Japan Kidney Disease Drugs Sales Breakdown by Type (2022-2027)
    9.3 Japan Kidney Disease Drugs Sales Breakdown by Application
        9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021)
        9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027)

10 Southeast Asia Kidney Disease Drugs Market Facts & Figures
    10.1 Southeast Asia Kidney Disease Drugs Sales by Company
        10.1.1 Southeast Asia Kidney Disease Drugs Sales by Company (2016-2021)
        10.1.2 Southeast Asia Kidney Disease Drugs Revenue by Company (2016-2021)
    10.2 Southeast Asia Kidney Disease Drugs Sales Breakdown by Type
        10.2.1 Southeast Asia Kidney Disease Drugs Sales Breakdown by Type (2016-2021)
        10.2.2 Southeast Asia Kidney Disease Drugs Sales Breakdown by Type (2022-2027)
    10.3 Southeast Asia Kidney Disease Drugs Sales Breakdown by Application
        10.3.1 Southeast Asia K Units Sales Breakdown by Application (2016-2021)
        10.3.2 Southeast Asia K Units Sales Breakdown by Application (2022-2027)

11 India Kidney Disease Drugs Market Facts & Figures
    11.1 India Kidney Disease Drugs Sales by Company
        11.1.1 India Kidney Disease Drugs Sales by Company (2016-2021)
        11.1.2 India Kidney Disease Drugs Revenue by Company (2016-2021)
    11.2 India Kidney Disease Drugs Sales Breakdown by Type
        11.2.1 India Kidney Disease Drugs Sales Breakdown by Type (2016-2021)
        11.2.2 India Kidney Disease Drugs Sales Breakdown by Type (2022-2027)
    11.3 India Kidney Disease Drugs Sales Breakdown by Application
        11.3.1 India Kidney Disease Drugs Sales Breakdown by Application (2016-2021)
        11.3.2 India Kidney Disease Drugs Sales Breakdown by Application (2022-2027)

12 Company Profiles and Key Figures in Kidney Disease Drugs Business
    12.1 GlaxoSmithKline
        12.1.1 GlaxoSmithKline Corporation Information
        12.1.2 GlaxoSmithKline Business Overview
        12.1.3 GlaxoSmithKline Kidney Disease Drugs Sales, Revenue and Gross Margin (2016-2021)
        12.1.4 GlaxoSmithKline Kidney Disease Drugs Products Offered
        12.1.5 GlaxoSmithKline Recent Development
    12.2 Sanofi
        12.2.1 Sanofi Corporation Information
        12.2.2 Sanofi Business Overview
        12.2.3 Sanofi Kidney Disease Drugs Sales, Revenue and Gross Margin (2016-2021)
        12.2.4 Sanofi Kidney Disease Drugs Products Offered
        12.2.5 Sanofi Recent Development
    12.3 Roche
        12.3.1 Roche Corporation Information
        12.3.2 Roche Business Overview
        12.3.3 Roche Kidney Disease Drugs Sales, Revenue and Gross Margin (2016-2021)
        12.3.4 Roche Kidney Disease Drugs Products Offered
        12.3.5 Roche Recent Development
    12.4 Pfizer
        12.4.1 Pfizer Corporation Information
        12.4.2 Pfizer Business Overview
        12.4.3 Pfizer Kidney Disease Drugs Sales, Revenue and Gross Margin (2016-2021)
        12.4.4 Pfizer Kidney Disease Drugs Products Offered
        12.4.5 Pfizer Recent Development
    12.5 AstraZeneca
        12.5.1 AstraZeneca Corporation Information
        12.5.2 AstraZeneca Business Overview
        12.5.3 AstraZeneca Kidney Disease Drugs Sales, Revenue and Gross Margin (2016-2021)
        12.5.4 AstraZeneca Kidney Disease Drugs Products Offered
        12.5.5 AstraZeneca Recent Development
    12.6 Keryx Biopharmaceuticals
        12.6.1 Keryx Biopharmaceuticals Corporation Information
        12.6.2 Keryx Biopharmaceuticals Business Overview
        12.6.3 Keryx Biopharmaceuticals Kidney Disease Drugs Sales, Revenue and Gross Margin (2016-2021)
        12.6.4 Keryx Biopharmaceuticals Kidney Disease Drugs Products Offered
        12.6.5 Keryx Biopharmaceuticals Recent Development
    12.7 Kissei Pharmaceutical
        12.7.1 Kissei Pharmaceutical Corporation Information
        12.7.2 Kissei Pharmaceutical Business Overview
        12.7.3 Kissei Pharmaceutical Kidney Disease Drugs Sales, Revenue and Gross Margin (2016-2021)
        12.7.4 Kissei Pharmaceutical Kidney Disease Drugs Products Offered
        12.7.5 Kissei Pharmaceutical Recent Development
    12.8 AbbVie
        12.8.1 AbbVie Corporation Information
        12.8.2 AbbVie Business Overview
        12.8.3 AbbVie Kidney Disease Drugs Sales, Revenue and Gross Margin (2016-2021)
        12.8.4 AbbVie Kidney Disease Drugs Products Offered
        12.8.5 AbbVie Recent Development
    12.9 Amgen
        12.9.1 Amgen Corporation Information
        12.9.2 Amgen Business Overview
        12.9.3 Amgen Kidney Disease Drugs Sales, Revenue and Gross Margin (2016-2021)
        12.9.4 Amgen Kidney Disease Drugs Products Offered
        12.9.5 Amgen Recent Development
    12.10 Teva Pharmaceutical Industries
        12.10.1 Teva Pharmaceutical Industries Corporation Information
        12.10.2 Teva Pharmaceutical Industries Business Overview
        12.10.3 Teva Pharmaceutical Industries Kidney Disease Drugs Sales, Revenue and Gross Margin (2016-2021)
        12.10.4 Teva Pharmaceutical Industries Kidney Disease Drugs Products Offered
        12.10.5 Teva Pharmaceutical Industries Recent Development
    12.11 Tianjin Tongrentang Group
        12.11.1 Tianjin Tongrentang Group Corporation Information
        12.11.2 Tianjin Tongrentang Group Business Overview
        12.11.3 Tianjin Tongrentang Group Kidney Disease Drugs Sales, Revenue and Gross Margin (2016-2021)
        12.11.4 Tianjin Tongrentang Group Kidney Disease Drugs Products Offered
        12.11.5 Tianjin Tongrentang Group Recent Development
    12.12 Jiangxi Jimin Kexin Jinshuibao Pharmaceutical
        12.12.1 Jiangxi Jimin Kexin Jinshuibao Pharmaceutical Corporation Information
        12.12.2 Jiangxi Jimin Kexin Jinshuibao Pharmaceutical Business Overview
        12.12.3 Jiangxi Jimin Kexin Jinshuibao Pharmaceutical Kidney Disease Drugs Sales, Revenue and Gross Margin (2016-2021)
        12.12.4 Jiangxi Jimin Kexin Jinshuibao Pharmaceutical Kidney Disease Drugs Products Offered
        12.12.5 Jiangxi Jimin Kexin Jinshuibao Pharmaceutical Recent Development
    12.13 Datong Liqun Pharmaceutical
        12.13.1 Datong Liqun Pharmaceutical Corporation Information
        12.13.2 Datong Liqun Pharmaceutical Business Overview
        12.13.3 Datong Liqun Pharmaceutical Kidney Disease Drugs Sales, Revenue and Gross Margin (2016-2021)
        12.13.4 Datong Liqun Pharmaceutical Kidney Disease Drugs Products Offered
        12.13.5 Datong Liqun Pharmaceutical Recent Development
    12.14 Hebei Ruisen Pharmaceutical
        12.14.1 Hebei Ruisen Pharmaceutical Corporation Information
        12.14.2 Hebei Ruisen Pharmaceutical Business Overview
        12.14.3 Hebei Ruisen Pharmaceutical Kidney Disease Drugs Sales, Revenue and Gross Margin (2016-2021)
        12.14.4 Hebei Ruisen Pharmaceutical Kidney Disease Drugs Products Offered
        12.14.5 Hebei Ruisen Pharmaceutical Recent Development
    12.15 Changxing Pharmaceutical
        12.15.1 Changxing Pharmaceutical Corporation Information
        12.15.2 Changxing Pharmaceutical Business Overview
        12.15.3 Changxing Pharmaceutical Kidney Disease Drugs Sales, Revenue and Gross Margin (2016-2021)
        12.15.4 Changxing Pharmaceutical Kidney Disease Drugs Products Offered
        12.15.5 Changxing Pharmaceutical Recent Development
    12.16 zhejiang Shengbokang Pharmaceutical
        12.16.1 zhejiang Shengbokang Pharmaceutical Corporation Information
        12.16.2 zhejiang Shengbokang Pharmaceutical Business Overview
        12.16.3 zhejiang Shengbokang Pharmaceutical Kidney Disease Drugs Sales, Revenue and Gross Margin (2016-2021)
        12.16.4 zhejiang Shengbokang Pharmaceutical Kidney Disease Drugs Products Offered
        12.16.5 zhejiang Shengbokang Pharmaceutical Recent Development

13 Kidney Disease Drugs Manufacturing Cost Analysis
    13.1 Kidney Disease Drugs Key Raw Materials Analysis
        13.1.1 Key Raw Materials
        13.1.2 Key Raw Materials Price Trend
        13.1.3 Key Suppliers of Raw Materials
    13.2 Proportion of Manufacturing Cost Structure
    13.3 Manufacturing Process Analysis of Kidney Disease Drugs
    13.4 Kidney Disease Drugs Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers
    14.1 Marketing Channel
    14.2 Kidney Disease Drugs Distributors List
    14.3 Kidney Disease Drugs Customers

15 Market Dynamics
    15.1 Kidney Disease Drugs Market Trends
    15.2 Kidney Disease Drugs Drivers
    15.3 Kidney Disease Drugs Market Challenges
    15.4 Kidney Disease Drugs Market Restraints

16 Research Findings and Conclusion

17 Appendix
    17.1 Research Methodology
        17.1.1 Methodology/Research Approach
        17.1.2 Data Source
    17.2 Author List
    17.3 Disclaimer
List of Tables
    Table 1. Global Kidney Disease Drugs Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
    Table 2. Global Kidney Disease Drugs Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
    Table 3. Global Kidney Disease Drugs Market Size (US$ Million) by Region: 2016 VS 2021 &2027
    Table 4. Global Kidney Disease Drugs Sales (K Units) by Region (2016-2021)
    Table 5. Global Kidney Disease Drugs Sales Market Share by Region (2016-2021)
    Table 6. Global Kidney Disease Drugs Revenue (US$ Million) Market Share by Region (2016-2021))
    Table 7. Global Kidney Disease Drugs Revenue Share by Region (2016-2021)
    Table 8. Global Kidney Disease Drugs Sales (K Units) Forecast by Region (2022-2027)
    Table 9. Global Kidney Disease Drugs Sales Market Share Forecast by Region (2022-2027)
    Table 10. Global Kidney Disease Drugs Revenue (US$ Million) Forecast by Region (2022-2027)
    Table 11. Global Kidney Disease Drugs Revenue Share Forecast by Region (2022-2027)
    Table 12. Global Kidney Disease Drugs Sales (K Units) of Key Companies (2016-2021)
    Table 13. Global Kidney Disease Drugs Sales Share by Company (2016-2021)
    Table 14. Global Kidney Disease Drugs Revenue (US$ Million) by Company (2016-2021)
    Table 15. Global Kidney Disease Drugs Revenue Share by Company (2016-2021)
    Table 16. Global Kidney Disease Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Kidney Disease Drugs as of 2020)
    Table 17. Global Kidney Disease Drugs Average Price (US$/Unit) of Key Company (2016-2021)
    Table 18. Manufacturers Kidney Disease Drugs Manufacturing Sites and Area Served
    Table 19. Manufacturers Kidney Disease Drugs Product Type
    Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 21. Global Kidney Disease Drugs Sales (K Units) by Type (2016-2021)
    Table 22. Global Kidney Disease Drugs Sales Share by Type (2016-2021)
    Table 23. Global Kidney Disease Drugs Revenue (US$ Million) Market Share by Type (2016-2021)
    Table 24. Global Kidney Disease Drugs Price (US$/Unit) by Type (2016-2021)
    Table 25. Global Kidney Disease Drugs Sales Share by Type (2022-2027)
    Table 26. Global Kidney Disease Drugs Revenue (US$ Million) Market Share by Type (2022-2027) 
    Table 27. Global Kidney Disease Drugs Revenue Share by Type (2022-2027)
    Table 28. Global Kidney Disease Drugs Price (US$/Unit) by Type (2022-2027)
    Table 29. Global Kidney Disease Drugs Sales (K Units) by Application (2016-2021) 
    Table 30. Global Kidney Disease Drugs Sales Share by Application (2016-2021)
    Table 31. Global Kidney Disease Drugs Revenue (US$ Million) Market Share by Application (2016-2021)
    Table 32. Global Kidney Disease Drugs Price (US$/Unit) by Application (2016-2021)
    Table 33. Global Kidney Disease Drugs Sales (K Units) by Application (2022-2027)
    Table 34. Global Kidney Disease Drugs Sales Share by Application (2022-2027)
    Table 35. Global Kidney Disease Drugs Revenue (US$ Million) Market Share by Application (2022-2027)
    Table 36. Global Kidney Disease Drugs Revenue Share by Application (2022-2027)
    Table 37. Global Kidney Disease Drugs Price (US$/Unit) by Application (2022-2027)
    Table 38. North America Kidney Disease Drugs Sales (K Units) by Company (2016-2021)
    Table 39. North America Kidney Disease Drugs Sales Market Share by Company (2016-2021)
    Table 40. North America Kidney Disease Drugs Revenue by Company (2016-2021) & (US$ Million)
    Table 41. North America Kidney Disease Drugs Revenue Market Share by Company (2016-2021)
    Table 42. North America Kidney Disease Drugs Sales by Type (2016-2021) & (K Units)
    Table 43. North America Kidney Disease Drugs Sales Market Share by Type (2016-2021)
    Table 44. North America Kidney Disease Drugs Sales by Type (2022-2027) & (K Units)
    Table 45. North America Kidney Disease Drugs Sales Market Share by Type (2022-2027)
    Table 46. North America Kidney Disease Drugs Sales by Application (2016-2021) & (K Units)
    Table 47. North America Kidney Disease Drugs Sales Market Share by Application (2016-2021)
    Table 48. North America Kidney Disease Drugs Sales by Application (2022-2027) & (K Units)
    Table 49. North America Kidney Disease Drugs Sales Market Share by Application (2022-2027)
    Table 50. Europe Kidney Disease Drugs Sales (K Units) by Company (2016-2021)
    Table 51. Europe Kidney Disease Drugs Sales Market Share by Company (2016-2021)
    Table 52. Europe Kidney Disease Drugs Revenue by Company (2016-2021) & (US$ Million)
    Table 53. Europe Kidney Disease Drugs Revenue Market Share by Company (2016-2021)
    Table 54. Europe Kidney Disease Drugs Sales by Type (2016-2021) & (K Units)
    Table 55. Europe Kidney Disease Drugs Sales Market Share by Type (2016-2021)
    Table 56. Europe Kidney Disease Drugs Sales by Type (2022-2027) & (K Units)
    Table 57. Europe Kidney Disease Drugs Sales Market Share by Type (2022-2027)
    Table 58. Europe Kidney Disease Drugs Sales by Application (2016-2021) & (K Units)
    Table 59. Europe Kidney Disease Drugs Sales Market Share by Application (2016-2021)
    Table 60. Europe Kidney Disease Drugs Sales by Application (2022-2027) & (K Units)
    Table 61. Europe Kidney Disease Drugs Sales Market Share by Application (2022-2027)
    Table 62. China Kidney Disease Drugs Sales (K Units) by Company (2016-2021)
    Table 63. China Kidney Disease Drugs Sales Market Share by Company (2016-2021)
    Table 64. China Kidney Disease Drugs Revenue by Company (2016-2021) & (US$ Million)
    Table 65. China Kidney Disease Drugs Revenue Market Share by Company (2016-2021)
    Table 66. China Kidney Disease Drugs Sales by Type (2016-2021) & (K Units)
    Table 67. China Kidney Disease Drugs Sales Market Share by Type (2016-2021)
    Table 68. China Kidney Disease Drugs Sales by Type (2022-2027) & (K Units)
    Table 69. China Kidney Disease Drugs Sales Market Share by Type (2022-2027)
    Table 70. China Kidney Disease Drugs Sales by Application (2016-2021) & (K Units)
    Table 71. China Kidney Disease Drugs Sales Market Share by Application (2016-2021)
    Table 72. China Kidney Disease Drugs Sales by Application (2022-2027) & (K Units)
    Table 73. China Kidney Disease Drugs Sales Market Share by Application (2022-2027)
    Table 74. Japan Kidney Disease Drugs Sales (K Units) by Company (2016-2021)
    Table 75. Japan Kidney Disease Drugs Sales Market Share by Company (2016-2021)
    Table 76. Japan Kidney Disease Drugs Revenue by Company (2016-2021) & (US$ Million)
    Table 77. Japan Kidney Disease Drugs Revenue Market Share by Company (2016-2021)
    Table 78. Japan Kidney Disease Drugs Sales by Type (2016-2021) & (K Units)
    Table 79. Japan Kidney Disease Drugs Sales Market Share by Type (2016-2021)
    Table 80. Japan Kidney Disease Drugs Sales by Type (2022-2027) & (K Units)
    Table 81. Japan Kidney Disease Drugs Sales Market Share by Type (2022-2027)
    Table 82. Japan Kidney Disease Drugs Sales by Application (2016-2021) & (K Units)
    Table 83. Japan Kidney Disease Drugs Sales Market Share by Application (2016-2021)
    Table 84. Japan Kidney Disease Drugs Sales by Application (2022-2027) & (K Units)
    Table 85. Japan Kidney Disease Drugs Sales Market Share by Application (2022-2027)
    Table 86. Southeast Asia Kidney Disease Drugs Sales (K Units) by Company (2016-2021)
    Table 87. Southeast Asia Kidney Disease Drugs Sales Market Share by Company (2016-2021)
    Table 88. Southeast Asia Kidney Disease Drugs Revenue by Company (2016-2021) & (US$ Million)
    Table 89. Southeast Asia Kidney Disease Drugs Revenue Market Share by Company (2016-2021)
    Table 90. Southeast Asia Kidney Disease Drugs Sales by Type (2016-2021) & (K Units)
    Table 91. Southeast Asia Kidney Disease Drugs Sales Market Share by Type (2016-2021)
    Table 92. Southeast Asia Kidney Disease Drugs Sales by Type (2022-2027) & (K Units)
    Table 93. Southeast Asia Kidney Disease Drugs Sales Market Share by Type (2022-2027)
    Table 94. Southeast Asia Kidney Disease Drugs Sales by Application (2016-2021) & (K Units)
    Table 95. Southeast Asia Kidney Disease Drugs Sales Market Share by Application (2016-2021)
    Table 96. Southeast Asia Kidney Disease Drugs Sales by Application (2022-2027) & (K Units)
    Table 97. Southeast Asia Kidney Disease Drugs Sales Market Share by Application (2022-2027)
    Table 98. India Kidney Disease Drugs Sales (K Units) by Company (2016-2021)
    Table 99. India Kidney Disease Drugs Sales Market Share by Company (2016-2021)
    Table 100. India Kidney Disease Drugs Revenue by Company (2016-2021) & (US$ Million)
    Table 101. India Kidney Disease Drugs Revenue Market Share by Company (2016-2021)
    Table 102. India Kidney Disease Drugs Sales by Type (2016-2021) & (K Units)
    Table 103. India Kidney Disease Drugs Sales Market Share by Type (2016-2021)
    Table 104. India Kidney Disease Drugs Sales by Type (2022-2027) & (K Units)
    Table 105. India Kidney Disease Drugs Sales Market Share by Type (2022-2027)
    Table 106. India Kidney Disease Drugs Sales by Application (2016-2021) & (K Units)
    Table 107. India Kidney Disease Drugs Sales Market Share by Application (2016-2021)
    Table 108. India Kidney Disease Drugs Sales by Application (2022-2027) & (K Units)
    Table 109. India Kidney Disease Drugs Sales Market Share by Application (2022-2027)
    Table 110. GlaxoSmithKline Corporation Information
    Table 111. GlaxoSmithKline Description and Business Overview
    Table 112. GlaxoSmithKline Kidney Disease Drugs Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 113. GlaxoSmithKline Kidney Disease Drugs Product
    Table 114. GlaxoSmithKline Recent Development
    Table 115. Sanofi Corporation Information
    Table 116. Sanofi Description and Business Overview
    Table 117. Sanofi Kidney Disease Drugs Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 118. Sanofi Kidney Disease Drugs Product
    Table 119. Sanofi Recent Development
    Table 120. Roche Corporation Information
    Table 121. Roche Description and Business Overview
    Table 122. Roche Kidney Disease Drugs Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 123. Roche Kidney Disease Drugs Product
    Table 124. Roche Recent Development
    Table 125. Pfizer Corporation Information
    Table 126. Pfizer Description and Business Overview
    Table 127. Pfizer Kidney Disease Drugs Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 128. Pfizer Kidney Disease Drugs Product
    Table 129. Pfizer Recent Development
    Table 130. AstraZeneca Corporation Information
    Table 131. AstraZeneca Description and Business Overview
    Table 132. AstraZeneca Kidney Disease Drugs Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 133. AstraZeneca Kidney Disease Drugs Product
    Table 134. AstraZeneca Recent Development
    Table 135. Keryx Biopharmaceuticals Corporation Information
    Table 136. Keryx Biopharmaceuticals Description and Business Overview
    Table 137. Keryx Biopharmaceuticals Kidney Disease Drugs Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 138. Keryx Biopharmaceuticals Kidney Disease Drugs Product
    Table 139. Keryx Biopharmaceuticals Recent Development
    Table 140. Kissei Pharmaceutical Corporation Information
    Table 141. Kissei Pharmaceutical Description and Business Overview
    Table 142. Kissei Pharmaceutical Kidney Disease Drugs Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 143. Kissei Pharmaceutical Kidney Disease Drugs Product
    Table 144. Kissei Pharmaceutical Recent Development
    Table 145. AbbVie Corporation Information
    Table 146. AbbVie Kidney Disease Drugs Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 147. AbbVie Description and Business Overview
    Table 148. AbbVie Kidney Disease Drugs Product
    Table 149. AbbVie Recent Development
    Table 150. Amgen Corporation Information
    Table 151. Amgen Kidney Disease Drugs Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 152. Amgen Description and Business Overview
    Table 153. Amgen Kidney Disease Drugs Product
    Table 154. Amgen Recent Development
    Table 155. Teva Pharmaceutical Industries Corporation Information
    Table 156. Teva Pharmaceutical Industries Description and Business Overview
    Table 157. Teva Pharmaceutical Industries Kidney Disease Drugs Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 158. Teva Pharmaceutical Industries Kidney Disease Drugs Product
    Table 159. Teva Pharmaceutical Industries Recent Development
    Table 160. Tianjin Tongrentang Group Corporation Information
    Table 161. Tianjin Tongrentang Group Description and Business Overview
    Table 162. Tianjin Tongrentang Group Kidney Disease Drugs Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 163. Tianjin Tongrentang Group Kidney Disease Drugs Product
    Table 164. Tianjin Tongrentang Group Recent Development
    Table 165. Jiangxi Jimin Kexin Jinshuibao Pharmaceutical Corporation Information
    Table 166. Jiangxi Jimin Kexin Jinshuibao Pharmaceutical Description and Business Overview
    Table 167. Jiangxi Jimin Kexin Jinshuibao Pharmaceutical Kidney Disease Drugs Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 168. Jiangxi Jimin Kexin Jinshuibao Pharmaceutical Kidney Disease Drugs Product
    Table 169. Jiangxi Jimin Kexin Jinshuibao Pharmaceutical Recent Development
    Table 170. Datong Liqun Pharmaceutical Corporation Information
    Table 171. Datong Liqun Pharmaceutical Description and Business Overview
    Table 172. Datong Liqun Pharmaceutical Kidney Disease Drugs Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 173. Datong Liqun Pharmaceutical Kidney Disease Drugs Product
    Table 174. Datong Liqun Pharmaceutical Recent Development
    Table 175. Hebei Ruisen Pharmaceutical Corporation Information
    Table 176. Hebei Ruisen Pharmaceutical Description and Business Overview
    Table 177. Hebei Ruisen Pharmaceutical Kidney Disease Drugs Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 178. Hebei Ruisen Pharmaceutical Kidney Disease Drugs Product
    Table 179. Hebei Ruisen Pharmaceutical Recent Development
    Table 180. Changxing Pharmaceutical Corporation Information
    Table 181. Changxing Pharmaceutical Description and Business Overview
    Table 182. Changxing Pharmaceutical Kidney Disease Drugs Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 183. Changxing Pharmaceutical Kidney Disease Drugs Product
    Table 184. Changxing Pharmaceutical Recent Development
    Table 185. zhejiang Shengbokang Pharmaceutical Corporation Information
    Table 186. zhejiang Shengbokang Pharmaceutical Description and Business Overview
    Table 187. zhejiang Shengbokang Pharmaceutical Kidney Disease Drugs Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 188. zhejiang Shengbokang Pharmaceutical Kidney Disease Drugs Product
    Table 189. zhejiang Shengbokang Pharmaceutical Recent Development
    Table 190. Production Base and Market Concentration Rate of Raw Material
    Table 191. Key Suppliers of Raw Materials
    Table 192. Kidney Disease Drugs Distributors List
    Table 193. Kidney Disease Drugs Customers List
    Table 194. Kidney Disease Drugs Market Trends
    Table 195. Kidney Disease Drugs Market Drivers
    Table 196. Kidney Disease Drugs Market Challenges
    Table 197. Kidney Disease Drugs Market Restraints
    Table 198. Research Programs/Design for This Report
    Table 199. Key Data Information from Secondary Sources
    Table 200. Key Data Information from Primary Sources
List of Figures
    Figure 1. Kidney Disease Drugs Product Picture
    Figure 2. Global Kidney Disease Drugs Sales Market Share by Type in 2021 & 2027
    Figure 3. Type I Product Picture
    Figure 4. Type II Product Picture
    Figure 5. Global Kidney Disease Drugs Sales Market Share by Application in 2021 & 2027
    Figure 6. Chronic Glomerulonephritis Examples
    Figure 7. Nephrotic Syndrome Examples
    Figure 8. Chronic Renal Failure Examples
    Figure 9. Kidney Stones Examples
    Figure 10. Renal Cyst (polycystic Kidney) Examples
    Figure 11. Diabetic Nephropathy Examples
    Figure 12. Hypertensive Nephropathy Examples
    Figure 13. Purpura Nephritis Examples
    Figure 14. Lupus Nephritis Examples
    Figure 15. Pediatric Kidney Disease Examples
    Figure 16. Global Kidney Disease Drugs Sales, (US$ Million), 2016 VS 2021 VS 2027
    Figure 17. Global Kidney Disease Drugs Sales Growth Rate (2016-2027) & (US$ Million)
    Figure 18. Global Kidney Disease Drugs Sales (K Units) Growth Rate (2016-2027)
    Figure 19. Global Kidney Disease Drugs Price Trends Growth Rate (2016-2027) (US$/Unit)
    Figure 20. Global Kidney Disease Drugs Revenue Market Share by Region: 2016 VS 2021
    Figure 21. Global Kidney Disease Drugs Revenue Market Share by Region: 2021 VS 2027
    Figure 22. North America Kidney Disease Drugs Revenue (Million USD) Growth Rate (2016-2027)
    Figure 23. North America Kidney Disease Drugs Sales (K Units) Growth Rate (2016-2027)
    Figure 24. Europe Kidney Disease Drugs Revenue (Million USD) Growth Rate (2016-2027)
    Figure 25. Europe Kidney Disease Drugs Sales (Million USD) Growth Rate (2016-2027)
    Figure 26. China Kidney Disease Drugs Revenue (Million USD) Growth Rate (2016-2027)
    Figure 27. China Kidney Disease Drugs Sales (Million USD) and Growth Rate (2016-2027)
    Figure 28. Japan Kidney Disease Drugs Revenue (Million USD) Growth Rate (2016-2027)
    Figure 29. Japan Kidney Disease Drugs Sales (Million USD) Growth Rate (2016-2027)
    Figure 30. Southeast Asia Kidney Disease Drugs Revenue (Million USD) Growth Rate (2016-2027)
    Figure 31. Southeast Asia Kidney Disease Drugs Sales (Million USD) Growth Rate (2016-2027)
    Figure 32. India Kidney Disease Drugs Revenue (Million USD) Growth Rate (2016-2027)
    Figure 33. India Kidney Disease Drugs Sales (Million USD) Growth Rate (2016-2027)
    Figure 34. Global 5 Largest Kidney Disease Drugs Players Market Share by Revenue in Kidney Disease Drugs: 2016 & 2020
    Figure 35. Kidney Disease Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
    Figure 36. Global Kidney Disease Drugs Revenue Share by Type (2016-2021)
    Figure 37. Global Kidney Disease Drugs Revenue Growth Rate by Type in 2016 & 2020
    Figure 38. Global Kidney Disease Drugs Revenue Share by Application (2016-2021)
    Figure 39. Global Kidney Disease Drugs Revenue Growth Rate by Application in 2016 & 2020
    Figure 40. North America Kidney Disease Drugs Sales Market Share by Type in 2020
    Figure 41. North America Kidney Disease Drugs Sales Market Share by Application in 2020
    Figure 42. Europe Kidney Disease Drugs Sales Market Share by Type in 2020
    Figure 43. Europe Kidney Disease Drugs Sales Market Share by Application in 2020
    Figure 44. China Kidney Disease Drugs Sales Market Share by Type in 2020
    Figure 45. China Kidney Disease Drugs Sales Market Share by Application in 2020
    Figure 46. Japan Kidney Disease Drugs Sales Market Share by Type in 2020
    Figure 47. Japan Kidney Disease Drugs Sales Market Share by Application in 2020
    Figure 48. Southeast Asia Kidney Disease Drugs Sales Market Share by Type in 2020
    Figure 49. Southeast Asia Kidney Disease Drugs Sales Market Share by Application in 2020
    Figure 50. India Kidney Disease Drugs Sales Market Share by Type in 2020
    Figure 51. India Kidney Disease Drugs Sales Market Share by Application in 2020
    Figure 52. Key Raw Materials Price Trend
    Figure 53. Manufacturing Cost Structure of Kidney Disease Drugs 
    Figure 54. Manufacturing Process Analysis of Kidney Disease Drugs
    Figure 55. Kidney Disease Drugs Industrial Chain Analysis
    Figure 56. Channels of Distribution
    Figure 57. Distributors Profiles
    Figure 58. Bottom-up and Top-down Approaches for This Report
    Figure 59. Data Triangulation 
    Figure 60. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
GlaxoSmithKline
Sanofi
Roche
Pfizer
AstraZeneca
Keryx Biopharmaceuticals
Kissei Pharmaceutical
AbbVie
Amgen
Teva Pharmaceutical Industries
Tianjin Tongrentang Group
Jiangxi Jimin Kexin Jinshuibao Pharmaceutical
Datong Liqun Pharmaceutical
Hebei Ruisen Pharmaceutical
Changxing Pharmaceutical
zhejiang Shengbokang Pharmaceutical
Frequently Asked Questions
Kidney Disease Drugs report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Kidney Disease Drugs report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Kidney Disease Drugs report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Modified Waxy Starch

The global Modified Waxy Starch market is segmented by company, region (country), by Type, and by ... Read More

Draught Fan

The global Draught Fan market is segmented by company, region (country), by Type, and by Applicat ... Read More